Deep Vein Thrombosis in Hospitalized Patients With COVID-19: Incidence, Distribution, Predictors, and Clinical Outcomes in a Brazilian Tertiary Center.

Although uncommon, deep vein thrombosis in hospitalized COVID-19 patients was associated with substantial morbidity and mortality. A prior history of venous thrombosis was the strongest predictor, identifying a high-risk subgroup.

The occurrence of clinically significant deep vein thrombosis despite routine pharmacological prophylaxis supports the need for risk-adapted diagnostic strategies, including targeted use of venous Doppler ultrasound.